Cutaneous histopathology of Sézary syndrome: A study of 41 cases with a proven circulating T-cell clone

Journal of Cutaneous Pathology

Volumn 24, Issue 5, 1997, Pages 286-291

  Trotter, M J ^a,d   Whittaker, S J ^b,c   Orchard, G E ^c   Smith, N P ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD; CELL CLONE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SEZARY SYNDROME; SKIN; T LYMPHOCYTE; ADULT; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; ERYTHRODERMA; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN TISSUE; LYMPHADENOPATHY; LYMPHOCYTE CLONE; MONONUCLEAR CELL; PRURITUS; SEZARY CELL; SKIN BIOPSY; SOUTHERN BLOTTING; SURVIVAL; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE;

AGED; AGED, 80 AND OVER; CLONE CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; SEZARY SYNDROME; SKIN; T-LYMPHOCYTES;

EID: 0030610963     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb00793.x     Document Type: Article

References (26)

1. Sézary A, Bouvrain Y. Erythrodermie avec presence de cellules monstreuses dans le derme et dans le sang circulant. Bull Soc Fr Dermatol Syph 1938: 45: 254.
2. Taswell HF, Winkelmann RK. Sézary syndrome - a malignant reticulemic erythroderma. J Am Med Assoc 1961: 177: 465.
3. Wieselthier JS, Koh HK. Sézary syndrome: diagnosis, prognosis, and critical renew of treatment options. J Am Acad Dermatol 1990: 22: 381.
4. Kuzel TM, Roenigk HH, Rosen ST. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol 1991: 9: 1298.
5. Zip C, Murray S, Walsh NMG. The specificity of histopathology of erythroderma. J Cutan Pathol 1993: 20: 393.
6. Walsh NMG, Prokopetz R, Tron VA, et al. Histopathology in erythroderma: review of a series of cases by multiple observers. J Cutan Pathol 1994: 21: 419.
7. Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides. Am J Dermatopathol 1988: 10: 469.
8. Olerud JE, Kulin PA, Chew DE, et al. Cutaneous T-cell lymphoma. Evaluation of pretreatment skin biopsy specimens by a panel of pathologists. Arch Dermatol 1992: 128: 501.
9. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 1994: 18: 645.
10. Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassesment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 1995: 19: 1423.
11. Sentis HJ, Willemze R, Scheffer E. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 1986: 15: 1217.
12. Winkelmann RK, Linman JW. Erythroderma with atypical lymphocytes (Sézary syndrome). Am J Med 1973: 55: 192.
13. Holdaway DR, Winkelmann RK. Histopathology of Sézary syndrome. Mayo Clin Proc 1974: 49: 541.
14. Buechner SA, Winkelmann RK. Sézary syndrome: a clinicopathologic study of 39 cases. Arch Dermatol 1983: 119: 979.
15. Weiss LM, Wood GS, Hu E, Abel EA, Hoppe RT, Sklar J. Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sézary syndrome. J Invest Dermatol 1989: 92: 601.
16. Bakels V, van Oostveen JW, Gordijn RJL, Walboomers JMM, Meijer CJLM, Willemze R. Diagnostic value of T-cell receptor beta gene rearrangement analysis on peripheral blood lymphocytes of patients with erythroderma. J Invest Dermatol 1991: 97: 782.
17. Whittaker SJ, Smith NP, Russell Jones R, Luzzatto L. Analysis of β, γ, and δ T-cell receptor genes in mycosis fungoides and Sézary syndrome. Cancer 1991: 68: 1572.
18. Zelickson BD, Peters MS, Muller SA, et al. T-cell gene rearrangement analysis: Cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. J Am Acad Dermatol 1991: 25: 787.
19. Foroni L, Catovsky D, Rabbitts T, Luzzatto L. DNA rearrangements of immunoglobulin genes correlates with phenotypic markers in B-cell malignancies. Mol Biol Med 1984: 2: 63.
20. Simms JE, Tunnacliffe A, Smith WJ, Rabbitts TH. Complexity of human T-cell antigen receptor chain constant and variable region genes. Nature 1984: 312: 541.
21. Flaxman BA, Zelazny G, Van Scott EJ. Nonspecificity of characteristic cells in mycosis fungoides. Arch Dermatol 1971: 104: 141.
22. Van der Loo EM, Meijer CJLM, Scheffer E, Van Vloten WA. The prognostic value of membrane markers and morphometric characteristics of lymphoid cells in blood and lymph nodes from patients with mycosis fungoides. Cancer 1981: 48: 738.
23. Duncan SC, Winkelmann RK. Circulating Sézary cells in hospitalized dermatology patients. Br J Dermatol 1978: 99: 171.
24. Flandrin G, Brouet J-C. The Sézary cell: cytologic, cytochemical, and immunologic studies. Mayo Clin Proc 1974: 49: 575.
25. Lutzner MA, Emerit I, Durepaire R, et al. Cytogenetic, cytomorphometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small cell variant. J Natl Cancer Inst 1973: 50: 1145.
26. Farber EM, Cox AJ, Steinberg J, McClintock RP. Therapy of mycosis fungoides with topically applied fluocinolone acetonide under occlusive dressing. Cancer 1966: 19: 237.